New Study Finds Aspirin Can Significantly Cut COVID Risks — And Even Death

The Blaze

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn

A new study finds that simple, over-the-counter aspirin may be able to protect COVID-19 patients from extreme risk, including the need for mechanical ventilation, the Jerusalem Post reported.

New research from George Washington University has determined that treating COVID patients with aspirin reduced the risk of severe illness by nearly half.

The report noted that an aspirin regimen in more than 400 COVID-19 patients in hospitals across the United States cut the need for ventilation by 44%, slashed ICU admission by 43%, and reduced overall in-hospital mortality rates by 47%.

Dr. Jonathan Chow, one of the study’s researchers, said, “As we learned about the connection between blood clots and COVID-19, we knew that aspirin — used to prevent stroke and heart attack — could be important for COVID-19 patients. Our research found an association between low-dose aspirin and decreased severity of COVID-19 and death.”

A low-dose aspirin regimen has long been touted as potentially lifesaving for people at risk of heart attack or stroke or who are afflicted by blood clotting issues.

Stories You May Like